Novel Building Blocks & Screening Libraries
Designed by medicinal chemists for medicinal chemists, our extensive range of Hit-to-Lead building blocks are specifically designed for lead optimization through structure activity relationship (SAR) development. We designed our building blocks to provide the following key features:
When mapped against the World Drug Index (WDI), it was shown that the Maybridge Screening Collection expresses ca. 87% of the 400,000 theoretical drug pharmacophores, indicating a far-reaching coverage of active moiety space which can generate a high impact in any screening program.
An independent study carried out by McGregor and Pallai comparing the diversity of 10 commercially available collections showed that out of those that were produced in-house, Maybridge had the most diverse library i.e. the most singletons (clusters with one member), and the highest number of clusters.
Library Fragment screening is becoming a method of choice in the quest for rapid identification of new lead molecules in drug discovery due to the higher hit probability and fewer fragments needing to be screened. The Maybridge fragment library is a proven, industry-leading library due to its diversity, pharmacophoric content and novelty.
To further increase the diversity and provide a greater coverage of lead-like chemical space we have redesigned our fragment library. The new library contains 2,500 carefully selected fragments, and it provides the optimal balance between broad coverage of lead-like diversity space and the number of fragments required to be screened.
Compounds to Facilitate Drug Discovery
From hit finding to lead optimization, the Maybridge™ portfolio offers a comprehensive range of chemistry products and services tailored to the drug discovery and biotechnology sector. For over 50 years, Maybridge products have been at the forefront of innovative heterocyclic building block design, fueled by the desire to access novel molecules of pharmaceutical interest.